JERUSALEM, Dec 8 – The scientific argument about whether population genetics studies should be based on homogenous or heterogeneous groups of people has given rise to a number of companies on either side of the debate.

Now a new start-up, IDGene Pharmaceuticals, has taken the debate to a new extreme, claiming that the population they have chosen to study is among the most homogenous out there.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.